Article Text
Prevention
Randomised controlled trial
Screening for type 2 diabetes does not reduce mortality over 10 years
Statistics from Altmetric.com
Commentary on: OpenUrlCrossRefPubMedWeb of Science
Context
Type 2 diabetes is a serious, increasingly common and costly disease. The number of people with diabetes has increased from 153 million in 1980 to 347 million in 2008.1 Effective preventive strategies to reduce the burden of type 2 diabetes and its complications are urgently needed. Population-based screening for type 2 diabetes may be such a strategy. Arguments in favour for diabetes screening are the large percentage of undiagnosed cases, the high-proportion of patients with complications at diagnosis and the long time between onset and diagnosis.2 However, uncertainty persists around the benefit …
Footnotes
-
Competing interests None.